🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. logo
Market Cap: Low
Employees: Medium

ZFP Technology Platform

Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company that develops genomic medicines using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation with a focus on transforming patients' lives.

Tags: Fabry disease, biotechnology, cell therapy, clinical trials, gene therapy, genome editing, genomics, hemophilia A, sickle cell disease

Symbol: SGMO

Recent Price: $2.34

Industry: Biotechnology

CEO: Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.

Sector: Healthcare

Employees: 405

Address: 501 Canal Blvd, Brisbane California, CALIFORNIA 94005

Phone: 510 970 6000

Leadership

  • Sandy Macrae, M.B., Ch.B., Ph.D.,
  • Gregory Davis, Ph.D., Head of Research and Technology
  • Nathalie Dubois-Stringfellow, Ph.D., Chief Development Officer
  • Prathyusha Duraibabu, Chief Financial Officer
  • Phillip Ramsey, Head of Technical Operations
  • Stephanie J. Seiler, CLP, Head of Business Development & Alliance Management
  • Louise Wilkie, Global Corporate Communications and Investor Relations
  • Scott Willoughby, General Counsel and Corporate Secretary
  • H. Stewart Parker, Chair of the Board
  • Courtney Beers, Ph.D.,
  • Robert Carey,
  • Kenneth Hillan, M.B. Ch.B.,
  • Margaret (Peg) A. Horn, J.D.,
  • John Markels, Ph.D.,
  • James R. Meyers,
  • Karen Smith, M.D., Ph.D., M.B.A., LLM,

Last updated: 2024-12-31